» Articles » PMID: 36814525

Metabolic Glycoengineering: A Promising Strategy to Remodel Microenvironments for Regenerative Therapy

Abstract

Cell-based regenerative therapy utilizes the differentiation potential of stem cells to rejuvenate tissues. But the dynamic fate of stem cells is calling for precise control to optimize their therapeutic efficiency. Stem cell fate is regulated by specific conditions called "microenvironments." Among the various factors in the microenvironment, the cell-surface glycan acts as a mediator of cell-matrix and cell-cell interactions and manipulates the behavior of cells. Herein, metabolic glycoengineering (MGE) is an easy but powerful technology for remodeling the structure of glycan. By presenting unnatural glycans on the surface, MGE provides us an opportunity to reshape the microenvironment and evoke desired cellular responses. In this review, we firstly focused on the determining role of glycans on cellular activity; then, we introduced how MGE influences glycosylation and subsequently affects cell fate; at last, we outlined the application of MGE in regenerative therapy, especially in the musculoskeletal system, and the future direction of MGE is discussed.

Citing Articles

Glycan Modifications as Regulators of Stem Cell Fate.

Alghazali R, Nugud A, El-Serafi A Biology (Basel). 2024; 13(2).

PMID: 38392295 PMC: 10886185. DOI: 10.3390/biology13020076.

References
1.
Du J, Agatemor C, Saeui C, Bhattacharya R, Jia X, Yarema K . Glycoengineering Human Neural and Adipose Stem Cells with Novel Thiol-Modified -Acetylmannosamine (ManNAc) Analogs. Cells. 2021; 10(2). PMC: 7918483. DOI: 10.3390/cells10020377. View

2.
Velikonja N, Urban J, Frohlich M, Neidlinger-Wilke C, Kletsas D, Potocar U . Cell sources for nucleus pulposus regeneration. Eur Spine J. 2013; 23 Suppl 3:S364-74. DOI: 10.1007/s00586-013-3106-9. View

3.
Wratil P, Horstkorte R . Metabolic Glycoengineering of Sialic Acid Using N-acyl-modified Mannosamines. J Vis Exp. 2017; (129). PMC: 5755472. DOI: 10.3791/55746. View

4.
Campbell C, Aich U, Weier C, Wang J, Choi S, Wen M . Targeting pro-invasive oncogenes with short chain fatty acid-hexosamine analogues inhibits the mobility of metastatic MDA-MB-231 breast cancer cells. J Med Chem. 2008; 51(24):8135-47. PMC: 2657678. DOI: 10.1021/jm800873k. View

5.
Muncie J, Weaver V . The Physical and Biochemical Properties of the Extracellular Matrix Regulate Cell Fate. Curr Top Dev Biol. 2018; 130:1-37. PMC: 6586474. DOI: 10.1016/bs.ctdb.2018.02.002. View